Published in Am J Psychiatry on January 04, 2010
Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A (2012) 5.67
Rethinking schizophrenia. Nature (2010) 4.85
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci (2011) 3.17
Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. Am J Psychiatry (2014) 2.51
Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology (2010) 2.20
Dendritic spine pathology in schizophrenia. Neuroscience (2012) 1.91
Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. Arch Gen Psychiatry (2010) 1.85
Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry (2015) 1.66
NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull (2012) 1.57
Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet (2013) 1.57
Microvascular abnormality in schizophrenia as shown by retinal imaging. Am J Psychiatry (2013) 1.53
The Dunedin Multidisciplinary Health and Development Study: overview of the first 40 years, with an eye to the future. Soc Psychiatry Psychiatr Epidemiol (2015) 1.51
Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am J Psychiatry (2014) 1.44
The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis. Schizophr Bull (2011) 1.43
Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry (2012) 1.40
A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. Neuropsychopharmacology (2012) 1.33
The myth of schizophrenia as a progressive brain disease. Schizophr Bull (2012) 1.21
Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review. Cogn Neuropsychiatry (2012) 1.19
The chandelier neuron in schizophrenia. Dev Neurobiol (2011) 1.18
Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects. Mol Psychiatry (2013) 1.11
The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan. Biol Psychiatry (2013) 1.11
The assessment of neuropsychological functioning in schizophrenia. Dialogues Clin Neurosci (2010) 1.10
Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull (2013) 1.10
Perisomatic inhibition and cortical circuit dysfunction in schizophrenia. Curr Opin Neurobiol (2011) 1.09
Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. Schizophr Bull (2013) 1.09
Cortical opioid markers in schizophrenia and across postnatal development. Cereb Cortex (2011) 1.06
Cortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions. Eur J Neurosci (2012) 1.04
Quantitative in vivo evidence for broad regional gradients in the timing of white matter maturation during adolescence. Neuroimage (2010) 1.04
Schizophrenia: from epidemiology to rehabilitation. Clin Pract Epidemiol Ment Health (2012) 1.02
Parvalbumin-containing chandelier and basket cell boutons have distinctive modes of maturation in monkey prefrontal cortex. J Neurosci (2013) 0.98
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology (2010) 0.97
Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia. Neurobiol Dis (2012) 0.97
The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortium. Biol Psychiatry (2012) 0.97
Neuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family Studies. Psychol Med (2012) 0.95
Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. Curr Pharm Biotechnol (2012) 0.95
Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study. Neuroimage (2014) 0.94
A familial risk enriched cohort as a platform for testing early interventions to prevent severe mental illness. BMC Psychiatry (2014) 0.94
Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia. Neurobiol Dis (2012) 0.92
Association of Genetic Risk for Schizophrenia With Nonparticipation Over Time in a Population-Based Cohort Study. Am J Epidemiol (2016) 0.92
Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectories. Schizophr Bull (2010) 0.91
The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci (2014) 0.91
Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions. Schizophr Bull (2015) 0.89
Defective processing speed and nonclinical psychotic experiences in children: longitudinal analyses in a large birth cohort. Am J Psychiatry (2013) 0.89
Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome. Neuropharmacology (2012) 0.89
Dopamine D4 receptor activation increases hippocampal gamma oscillations by enhancing synchronization of fast-spiking interneurons. PLoS One (2012) 0.88
A Swedish National Prospective and Co-relative Study of School Achievement at Age 16, and Risk for Schizophrenia, Other Nonaffective Psychosis, and Bipolar Illness. Schizophr Bull (2015) 0.88
Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia. Schizophr Res (2012) 0.87
Schizophrenia genetic variants are not associated with intelligence. Psychol Med (2013) 0.87
Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment. Eur Arch Psychiatry Clin Neurosci (2013) 0.87
Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry (2016) 0.86
The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia. Rev Neurosci (2012) 0.86
Neurocognitive functioning in schizophrenia and during the early phases of psychosis: targeting cognitive remediation interventions. Biomed Res Int (2013) 0.85
Genetic architecture of declarative memory: implications for complex illnesses. Neuroscientist (2011) 0.85
Using latent class growth analysis to form trajectories of premorbid adjustment in schizophrenia. J Abnorm Psychol (2012) 0.84
From antipsychotic to anti-schizophrenia drugs: role of animal models. Trends Pharmacol Sci (2012) 0.84
Cortical thickness and surface area in neonates at high risk for schizophrenia. Brain Struct Funct (2014) 0.84
Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals. JAMA Psychiatry (2014) 0.84
Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia. Biol Psychiatry (2016) 0.83
Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls. Schizophr Bull (2015) 0.82
The developmental course of executive functioning in schizophrenia. Int J Dev Neurosci (2010) 0.82
Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry (2016) 0.82
Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis. Schizophr Res (2013) 0.81
Young offspring at genetic risk of adult psychoses: the form of the trajectory of IQ or memory may orient to the right dysfunction at the right time. PLoS One (2011) 0.81
Early Childhood IQ Trajectories in Individuals Later Developing Schizophrenia and Affective Psychoses in the New England Family Studies. Schizophr Bull (2015) 0.81
Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. BMC Psychiatry (2013) 0.81
Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients. Schizophr Bull (2015) 0.80
Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia. Biol Psychiatry (2015) 0.80
Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome. Schizophr Bull (2015) 0.79
Reliability and validity of the CogState battery Chinese language version in schizophrenia. PLoS One (2013) 0.79
Prefrontal cortical GABA modulation of spatial reference and working memory. Int J Neuropsychopharmacol (2014) 0.79
Impaired fear memory specificity associated with deficient endocannabinoid-dependent long-term plasticity. Neuropsychopharmacology (2014) 0.78
The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis. Psychol Med (2015) 0.78
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia. Schizophr Bull (2015) 0.78
Clinical correlates of parametric digit-symbol substitution test in schizophrenia. Asian J Psychiatr (2014) 0.78
Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study. Transl Psychiatry (2015) 0.78
Psychotic Experiences, Working Memory, and the Developing Brain: A Multimodal Neuroimaging Study. Cereb Cortex (2015) 0.78
Zeroing in on early cognitive development in schizophrenia. Am J Psychiatry (2014) 0.77
The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement. PLoS One (2016) 0.77
A structure-function mechanism for schizophrenia. Front Psychiatry (2012) 0.76
Evidence of Common Genetic Overlap Between Schizophrenia and Cognition. Schizophr Bull (2015) 0.76
Altered Fronto-Temporal Functional Connectivity in Individuals at Ultra-High-Risk of Developing Psychosis. PLoS One (2015) 0.76
Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia. Am J Psychiatry (2016) 0.76
Investigating the cognitive antecedents of schizophrenia. Am J Psychiatry (2010) 0.76
Previous Institutionalization Is Followed by Broader Amygdala-Hippocampal-PFC Network Connectivity during Aversive Learning in Human Development. J Neurosci (2016) 0.76
Poor school performance in offspring of patients with schizophrenia: what are the mechanisms? Psychol Med (2011) 0.76
Recovery, not progressive deterioration, should be the expectation in schizophrenia. World Psychiatry (2015) 0.76
A simple spatial working memory and attention test on paired symbols shows developmental deficits in schizophrenia patients. Neural Plast (2013) 0.75
Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Mol Psychiatry (2014) 0.75
Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians. Harv Rev Psychiatry (2016) 0.75
Psychotic disorder and educational achievement: a family-based analysis. Soc Psychiatry Psychiatr Epidemiol (2015) 0.75
Psychotic Experiences and Working Memory: A Population-Based Study Using Signal-Detection Analysis. PLoS One (2016) 0.75
Development of abbreviated eight-item form of the Penn Verbal Reasoning Test. Assessment (2014) 0.75
Empirically defined patterns of executive function deficits in schizophrenia and their relation to everyday functioning: a person-centered approach. Clin Neuropsychol (2012) 0.75
An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity. Neuropharmacology (2015) 0.75
From Shortage to Surge: A Developmental Switch in Hippocampal-Prefrontal Coupling in a Gene-Environment Model of Neuropsychiatric Disorders. Cereb Cortex (2016) 0.75
Alterations in a Unique Class of Cortical Chandelier Cell Axon Cartridges in Schizophrenia. Biol Psychiatry (2016) 0.75
Childhood abuse and neglect may induce deficits in cognitive precursors of psychosis in high-risk children. J Psychiatry Neurosci (2015) 0.75
Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia. Transl Psychiatry (2015) 0.75
Academic Performance in Children of Mothers With Schizophrenia and Other Severe Mental Illness, and Risk for Subsequent Development of Psychosis: A Population-Based Study. Schizophr Bull (2016) 0.75
Insights into the Brain: Neuroimaging of Brain Development and Maturation. J Neuroimaging Psychiatry Neurol (2016) 0.75
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry (2007) 6.20
Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34
Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry (2007) 4.44
Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry (2000) 4.35
Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet (1994) 4.28
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci (1994) 3.77
The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry (2005) 3.68
Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry (1999) 3.61
Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry (2008) 3.27
Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry (2007) 3.23
Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol (2000) 3.17
A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry (2004) 2.65
Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull (1984) 2.48
IQ and risk for schizophrenia: a population-based cohort study. Psychol Med (1997) 2.47
Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry (2002) 2.30
Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull (2007) 2.25
Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. Am J Psychiatry (2008) 2.19
Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry (2001) 2.08
Relative risk of attention deficits in siblings of patients with schizophrenia. Am J Psychiatry (2000) 2.07
Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull (2000) 1.78
Developmental precursors of affective illness in a general population birth cohort. Arch Gen Psychiatry (1997) 1.70
A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry (2003) 1.63
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry (2005) 1.55
Cognitive ability in early adulthood and risk of 5 specific psychiatric disorders in middle age: the Vietnam experience study. Arch Gen Psychiatry (2008) 1.51
Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Arch Gen Psychiatry (1992) 1.49
Cognitive epidemiology. J Epidemiol Community Health (2007) 1.44
Cognitive development in schizophrenia: follow-back from the first episode. J Clin Exp Neuropsychol (2006) 1.42
Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 year follow-up study. J Clin Exp Neuropsychol (2006) 1.32
Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res (2003) 1.26
The natural history of change in intellectual performance: who changes? How much? Is it meaningful? J Child Psychol Psychiatry (1993) 1.25
The surprisingly rich contours of schizophrenia epidemiology. Arch Gen Psychiatry (2007) 1.22
Neurobehavioral deficits in offspring of schizophrenic parents: liability indicators and predictors of illness. Am J Med Genet (2000) 1.19
Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis. Am J Psychiatry (2002) 1.12
The schizophrenia prodrome. Am J Psychiatry (2006) 1.01
Why does postpsychotic IQ decline in childhood-onset schizophrenia? Am J Psychiatry (1999) 0.84
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med (2005) 28.99
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Role of genotype in the cycle of violence in maltreated children. Science (2002) 13.50
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry (2006) 9.44
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
A gradient of childhood self-control predicts health, wealth, and public safety. Proc Natl Acad Sci U S A (2011) 8.57
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry (2003) 7.28
A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med (2003) 7.03
Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry (2010) 6.15
Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry (2004) 5.95
Developmental trajectories of childhood disruptive behaviors and adolescent delinquency: a six-site, cross-national study. Dev Psychol (2003) 5.87
Males on the life-course-persistent and adolescence-limited antisocial pathways: follow-up at age 26 years. Dev Psychopathol (2002) 5.75
Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A (2012) 5.67
Association between children's experience of socioeconomic disadvantage and adult health: a life-course study. Lancet (2002) 5.32
Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci (2006) 5.25
A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01
Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry (2006) 4.92
Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: a longitudinal study. Lancet (2002) 4.89
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry (2005) 4.85
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull (2005) 4.66
Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci U S A (2007) 4.58
Identifying risk for obesity in early childhood. Pediatrics (2006) 4.50
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46
Association between child and adolescent television viewing and adult health: a longitudinal birth cohort study. Lancet (2004) 4.23
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry (2006) 4.12
Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet (2012) 4.05
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry (2005) 4.01
Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99
A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry (2002) 3.95
Differences in early childhood risk factors for juvenile-onset and adult-onset depression. Arch Gen Psychiatry (2002) 3.84
Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry (2005) 3.78
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. Am J Psychiatry (2006) 3.72
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry (2002) 3.59
Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med (2009) 3.41
Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study. Am J Psychiatry (2010) 3.36
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Life with (or without) father: the benefits of living with two biological parents depend on the father's antisocial behavior. Child Dev (2003) 3.30
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry (2008) 3.29
Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry (2007) 3.23
Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry (2013) 3.16
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Am J Psychiatry (2006) 3.12
Female and male antisocial trajectories: from childhood origins to adult outcomes. Dev Psychopathol (2008) 3.07
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ (2002) 3.06
Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet (2011) 2.99
Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry (2008) 2.82
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Symmetries in human brain language pathways correlate with verbal recall. Proc Natl Acad Sci U S A (2007) 2.78
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Am J Psychiatry (2007) 2.75
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Polygenic risk, rapid childhood growth, and the development of obesity: evidence from a 4-decade longitudinal study. Arch Pediatr Adolesc Med (2012) 2.70
Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies. J Child Psychol Psychiatry (2003) 2.69
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. Am J Psychiatry (2007) 2.68
Evidence for substantial genetic risk for psychopathy in 7-year-olds. J Child Psychol Psychiatry (2005) 2.64
Longitudinal evidence that psychopathy scores in early adolescence predict adult psychopathy. J Abnorm Psychol (2007) 2.62